Search

Your search keyword '"Mueller DL"' showing total 104 results

Search Constraints

Start Over You searched for: Author "Mueller DL" Remove constraint Author: "Mueller DL"
104 results on '"Mueller DL"'

Search Results

1. P021 Differential ACPA binding to nuclear antigens reveals a distinct subset of acetylation cross-reactive autoantibodies in rheumatoid arthritis

2. A2.33 Citrullinated self antigen-specific blood B cells carry cross-reactive immunoglobulins with effector potential

Catalog

Books, media, physical & digital resources

3. Decay channels of AlL2,3excitons and the absence of OKexcitons in α-Al2O3

4. Intermediate coupling inL2-L3core excitons of MgO,Al2O3, andSiO2

5. Resonant absorption and emission from localized core-hole states in Al2O3 and SiO2

8. BATF represses BIM to sustain tolerant T cells in the periphery.

9. Immune tolerance of food is mediated by layers of CD4 + T cell dysfunction.

10. Characteristics and in-hospital outcomes of patients undergoing complex bifurcation versus nonbifurcation percutaneous coronary intervention.

11. Different Hierarchies of Anti-Modified Protein Autoantibody Reactivities in Rheumatoid Arthritis.

12. Bronchoperitoneal and Enterocutaneous Fistula Development Following a Colorectal Anastomosis Leak.

13. Adenosine 2a Receptor Signal Blockade of Murine Autoimmune Arthritis via Inhibition of Pathogenic Germinal Center-Follicular Helper T Cells.

14. Recognition of Amino Acid Motifs, Rather Than Specific Proteins, by Human Plasma Cell-Derived Monoclonal Antibodies to Posttranslationally Modified Proteins in Rheumatoid Arthritis.

15. Differential ACPA Binding to Nuclear Antigens Reveals a PAD-Independent Pathway and a Distinct Subset of Acetylation Cross-Reactive Autoantibodies in Rheumatoid Arthritis.

16. Alum adjuvant is more effective than MF59 at prompting early germinal center formation in response to peptide-protein conjugates and enhancing efficacy of a vaccine against opioid use disorders.

17. Pathogenic Citrulline-Multispecific B Cell Receptor Clades in Rheumatoid Arthritis.

18. Variable domain N-linked glycosylation and negative surface charge are key features of monoclonal ACPA: Implications for B-cell selection.

19. Role of bone marrow-derived CD11c + dendritic cells in systolic overload-induced left ventricular inflammation, fibrosis and hypertrophy.

20. Relationship between CD4 Regulatory T Cells and Anergy In Vivo.

21. Cutting Edge: Adenosine A2a Receptor Signals Inhibit Germinal Center T Follicular Helper Cell Differentiation during the Primary Response to Vaccination.

22. CD4(+) T cell anergy prevents autoimmunity and generates regulatory T cell precursors.

23. The frequency of naive and early-activated hapten-specific B cell subsets dictates the efficacy of a therapeutic vaccine against prescription opioid abuse.

24. Absence of clinical findings reliably excludes unstable cervical spine injuries in children 5 years or younger.

25. Natural history and clinical implications of nondepressed skull fracture in young children.

26. Cutting edge: type 1 diabetes occurs despite robust anergy among endogenous insulin-specific CD4 T cells in NOD mice.

27. Macrophage scavenger receptor 1 (Msr1, SR-A) influences B cell autoimmunity by regulating soluble autoantigen concentration.

28. Murine thymic selection quantified using a unique method to capture deleted T cells.

29. Deletion and anergy of polyclonal B cells specific for ubiquitous membrane-bound self-antigen.

30. Estimating thyroid dose in pediatric CT exams from surface dose measurement.

31. Arthritogenic self-reactive CD4+ T cells acquire an FR4hiCD73hi anergic state in the presence of Foxp3+ regulatory T cells.

32. Pregnancy and rheumatoid arthritis: insights into the immunology of fetal tolerance and control of autoimmunity.

33. Pediatric radiation exposure during the initial evaluation for blunt trauma.

34. Mechanisms maintaining peripheral tolerance.

35. Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory.

36. Casitas B-lineage lymphoma b inhibits antigen recognition and slows cell cycle progression at late times during CD4+ T cell clonal expansion.

37. Langerhans cells are not required for efficient skin graft rejection.

38. Proliferating CD4+ T cells undergo immediate growth arrest upon cessation of TCR signaling in vivo.

39. Allopeptide-specific CD4(+) T cells facilitate the differentiation of directly alloreactive graft-infiltrating CD8(+) T Cells.

40. mTOR at the crossroads of T cell proliferation and tolerance.

41. Linking diacylglycerol kinase to T cell anergy.

42. p300/Cyclic AMP-responsive element binding-binding protein mediates transcriptional coactivation by the CD28 T cell costimulatory receptor.

43. Sustained B7/CD28 interactions and resultant phosphatidylinositol 3-kinase activity maintain G1-->S phase transitions at an optimal rate.

44. CD25+Foxp3+ regulatory T cells facilitate CD4+ T cell clonal anergy induction during the recovery from lymphopenia.

45. Prolonged TCR/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin.

46. Gene expression profiling in murine obliterative airway disease.

47. Sharing of class I MHC molecules between donor and host promotes the infiltration of allografts by mHAg-reactive CD8 T cells.

48. E3 ubiquitin ligases and their control of T cell autoreactivity.

49. Visualizing the first 50 hr of the primary immune response to a soluble antigen.

50. E3 ubiquitin ligases as T cell anergy factors.